EU regulators advocates use of Pfizer-BioNTech vaccines for adolescents


After United States and Canada, Europe’s medicines regulator today endorsed the use of Pfizer’s COVID-19 vaccine for children who are as young as 12 years of age.

The European Medicines Agency’s endorsement comes weeks after it began evaluating extending use of the vaccine, developed with Germany’s BioNTech, to include 12- to 15-year old’s. It is already being used in the European Union for those aged 16 and older

Earlier this month, US-based Centers for Disease Control approved the use of the vaccine for the children in the age group of 12-15 years.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 14 to 0, with one recusal to support the two-dose vaccine’s emergency authorization after it was cleared by the Food and Drug Administration, a Bloomberg report stated. CDC Director Rochelle Walensky adopted the recommendation after the vote, according to a statement from the agency

Recommended For You